| scholarly article | Q13442814 |
| P2093 | author name string | Cynthia Levy | |
| Jen-Jung Pan | |||
| Iliana Doycheva | |||
| Chaoru Chen | |||
| P2860 | cites work | Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients | Q34462959 |
| Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up | Q35090649 | ||
| Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis | Q35594898 | ||
| Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort | Q35596580 | ||
| Four year follow up of fatigue in a geographically defined primary biliary cirrhosis patient cohort | Q35760389 | ||
| Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis | Q35760984 | ||
| Primary biliary cirrhosis in The Netherlands. An analysis of associated diseases, cardiovascular risk, and malignancies on the basis of mortality figures. | Q39547593 | ||
| Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations | Q43120578 | ||
| Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up | Q43239506 | ||
| Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment | Q43270979 | ||
| Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk? | Q43676662 | ||
| Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid | Q43893454 | ||
| Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease | Q43929837 | ||
| Population prevalence and symptom associations of autonomic dysfunction in primary biliary cirrhosis. | Q53190185 | ||
| Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. | Q53856911 | ||
| Primary biliary cirrhosis | Q56854243 | ||
| Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics | Q72371479 | ||
| Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis | Q72736523 | ||
| An exploratory population-based case-control study of primary biliary cirrhosis | Q73746110 | ||
| Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation | Q80459292 | ||
| P433 | issue | 4 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| primary biliary cholangitis | Q1072420 | ||
| P304 | page(s) | 93-98 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | World Journal of Hepatology | Q27723328 |
| P1476 | title | Asymptomatic primary biliary cirrhosis is not associated with increased frequency of cardiovascular disease | |
| P478 | volume | 3 |
| Q38358553 | Coronary artery disease in primary biliary cirrhosis: A systematic review and meta-analysis of observational studies. |
| Q92685166 | Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study |
| Q90014773 | Primary biliary cholangitis presenting as acute ischemic stroke: A rare association |
| Q50995354 | Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis. |
| Q55395737 | Risk of Cardiovascular Events in Patients with Primary Biliary Cholangitis - Systematic Review. |
| Q34415169 | Risk of incident coronary artery disease in patients with primary biliary cirrhosis |
Search more.